Nasdaq:US$15.84 (+0.63) | HKEX:HK$24.80 (-0.30) | AIM:£2.35 (+0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models